Cargando…
Quantification of Women Who Could Benefit from Hormone Therapy after Endometrial Cancer Treatment: An Analysis of SEER Data
Our primary aim was to estimate the magnitude of stage I endometrial cancer (EC) survivors that could benefit from hormonal therapy (HT). Our secondary aims were to assess EC incidence in women below 50 and below 60 over the years, and analyze the overall survival and any influencing factors. We ana...
Autores principales: | Londero, Ambrogio P., Xholli, Anjeza, Bertozzi, Serena, Orsaria, Maria, Paudice, Michele, Mariuzzi, Laura, Cagnacci, Angelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777495/ https://www.ncbi.nlm.nih.gov/pubmed/36547135 http://dx.doi.org/10.3390/curroncol29120721 |
Ejemplares similares
-
COVID-19 and hormonal contraception
por: Cagnacci, Angelo, et al.
Publicado: (2022) -
Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review
por: Bertozzi, Serena, et al.
Publicado: (2023) -
Hormone Replacement Therapy in Endometrial Cancer Survivors: A Meta-Analysis
por: Londero, Ambrogio P., et al.
Publicado: (2021) -
Factors influencing the effect of external cephalic version: a retrospective nationwide cohort analysis
por: Londero, Ambrogio P., et al.
Publicado: (2022) -
Assisted Reproductive Technology and Breech Delivery: A Nationwide Cohort Study in Singleton Pregnancies
por: Londero, Ambrogio P., et al.
Publicado: (2023)